Ntikoudi, A.; Papachristou, A.; Tsalkitzi, A.; Margari, N.; Evangelou, E.; Vlachou, E.
Metabolic-Associated Steatotic Liver Disease (MASLD) and Type 2 Diabetes: Mechanisms, Diagnostic Approaches, and Therapeutic Interventions. Diabetology 2025, 6, 23.
https://doi.org/10.3390/diabetology6040023
AMA Style
Ntikoudi A, Papachristou A, Tsalkitzi A, Margari N, Evangelou E, Vlachou E.
Metabolic-Associated Steatotic Liver Disease (MASLD) and Type 2 Diabetes: Mechanisms, Diagnostic Approaches, and Therapeutic Interventions. Diabetology. 2025; 6(4):23.
https://doi.org/10.3390/diabetology6040023
Chicago/Turabian Style
Ntikoudi, Anastasia, Anastasia Papachristou, Afroditi Tsalkitzi, Nikoletta Margari, Eleni Evangelou, and Eugenia Vlachou.
2025. "Metabolic-Associated Steatotic Liver Disease (MASLD) and Type 2 Diabetes: Mechanisms, Diagnostic Approaches, and Therapeutic Interventions" Diabetology 6, no. 4: 23.
https://doi.org/10.3390/diabetology6040023
APA Style
Ntikoudi, A., Papachristou, A., Tsalkitzi, A., Margari, N., Evangelou, E., & Vlachou, E.
(2025). Metabolic-Associated Steatotic Liver Disease (MASLD) and Type 2 Diabetes: Mechanisms, Diagnostic Approaches, and Therapeutic Interventions. Diabetology, 6(4), 23.
https://doi.org/10.3390/diabetology6040023
